Asthma in Pregnancy

Vanessa E. Murphy; Marleen Bokern; Karen McLaughlin; Peter G. Gibson

doi:10.1016/B978-0-08-102723-3.00107-4

Asthma in Pregnancy

Vanessa E. Murphy, Marleen Bokern, Karen McLaughlin, Peter G. Gibson

Research output: Chapter in Book / Conference Paper › Chapter › peer-review

Abstract

Worldwide, 3–12% of pregnant women have asthma, making it one of the most common chronic conditions to affect pregnancy. Maternal asthma is associated with an increased risk of adverse perinatal outcomes, notably low birth weight and preterm birth, which are further increased with asthma exacerbations or oral corticosteroid use in pregnancy. Guidelines recommend use of medication as for non-pregnant adults with asthma, regular monitoring and a multi-disciplinary management approach. Exacerbations occur commonly, with risk factors including severe asthma, obesity, smoking and respiratory viral infection. Further research is needed to optimize outcomes for both mothers with asthma, and their infants.

Original language	English
Title of host publication	Encyclopedia of Respiratory Medicine, Second Edition
Publisher	Elsevier
Pages	369-382
Number of pages	14
Volume	2
ISBN (Electronic)	9780081027240
ISBN (Print)	9780081027233
DOIs	https://doi.org/10.1016/B978-0-08-102723-3.00107-4
Publication status	Published - 1 Jan 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Ltd. All rights reserved

Keywords

Asthma
Autism
Bronchiolitis
Exacerbation
Exhaled nitric oxide
Low birth weight
Pregnancy
Preterm birth
Self-management
T2 inflammation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-08-102723-3.00107-4

Cite this

@inbook{f8a929516b34416895e551805f50d0e0,

title = "Asthma in Pregnancy",

abstract = "Worldwide, 3–12% of pregnant women have asthma, making it one of the most common chronic conditions to affect pregnancy. Maternal asthma is associated with an increased risk of adverse perinatal outcomes, notably low birth weight and preterm birth, which are further increased with asthma exacerbations or oral corticosteroid use in pregnancy. Guidelines recommend use of medication as for non-pregnant adults with asthma, regular monitoring and a multi-disciplinary management approach. Exacerbations occur commonly, with risk factors including severe asthma, obesity, smoking and respiratory viral infection. Further research is needed to optimize outcomes for both mothers with asthma, and their infants.",

keywords = "Asthma, Autism, Bronchiolitis, Exacerbation, Exhaled nitric oxide, Low birth weight, Pregnancy, Preterm birth, Self-management, T2 inflammation",

author = "Murphy, {Vanessa E.} and Marleen Bokern and Karen McLaughlin and Gibson, {Peter G.}",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/B978-0-08-102723-3.00107-4",

language = "English",

isbn = "9780081027233",

volume = "2",

pages = "369--382",

booktitle = "Encyclopedia of Respiratory Medicine, Second Edition",

publisher = "Elsevier",

}

TY - CHAP

T1 - Asthma in Pregnancy

AU - Murphy, Vanessa E.

AU - Bokern, Marleen

AU - McLaughlin, Karen

AU - Gibson, Peter G.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Worldwide, 3–12% of pregnant women have asthma, making it one of the most common chronic conditions to affect pregnancy. Maternal asthma is associated with an increased risk of adverse perinatal outcomes, notably low birth weight and preterm birth, which are further increased with asthma exacerbations or oral corticosteroid use in pregnancy. Guidelines recommend use of medication as for non-pregnant adults with asthma, regular monitoring and a multi-disciplinary management approach. Exacerbations occur commonly, with risk factors including severe asthma, obesity, smoking and respiratory viral infection. Further research is needed to optimize outcomes for both mothers with asthma, and their infants.

AB - Worldwide, 3–12% of pregnant women have asthma, making it one of the most common chronic conditions to affect pregnancy. Maternal asthma is associated with an increased risk of adverse perinatal outcomes, notably low birth weight and preterm birth, which are further increased with asthma exacerbations or oral corticosteroid use in pregnancy. Guidelines recommend use of medication as for non-pregnant adults with asthma, regular monitoring and a multi-disciplinary management approach. Exacerbations occur commonly, with risk factors including severe asthma, obesity, smoking and respiratory viral infection. Further research is needed to optimize outcomes for both mothers with asthma, and their infants.

KW - Asthma

KW - Autism

KW - Bronchiolitis

KW - Exacerbation

KW - Exhaled nitric oxide

KW - Low birth weight

KW - Pregnancy

KW - Preterm birth

KW - Self-management

KW - T2 inflammation

UR - http://www.scopus.com/inward/record.url?scp=85143099011&partnerID=8YFLogxK

U2 - 10.1016/B978-0-08-102723-3.00107-4

DO - 10.1016/B978-0-08-102723-3.00107-4

M3 - Chapter

AN - SCOPUS:85143099011

SN - 9780081027233

VL - 2

SP - 369

EP - 382

BT - Encyclopedia of Respiratory Medicine, Second Edition

PB - Elsevier

ER -

Asthma in Pregnancy

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this